Kora Saude Participacoes SA
BOVESPA:KRSA3
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.59
14
|
Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one KRSA3 stock under the Base Case scenario is 26.81 BRL. Compared to the current market price of 6.63 BRL, Kora Saude Participacoes SA is Undervalued by 75%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Kora Saude Participacoes SA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for KRSA3 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Kora Saude Participacoes SA
Balance Sheet Decomposition
Kora Saude Participacoes SA
Current Assets | 1.4B |
Cash & Short-Term Investments | 228m |
Receivables | 951.4m |
Other Current Assets | 227.6m |
Non-Current Assets | 3.3B |
Long-Term Investments | 6.3m |
PP&E | 1.3B |
Intangibles | 1.9B |
Other Non-Current Assets | 169m |
Current Liabilities | 870.4m |
Accounts Payable | 435m |
Other Current Liabilities | 435.4m |
Non-Current Liabilities | 3B |
Long-Term Debt | 2.4B |
Other Non-Current Liabilities | 512.4m |
Earnings Waterfall
Kora Saude Participacoes SA
Revenue
|
2.3B
BRL
|
Cost of Revenue
|
-1.8B
BRL
|
Gross Profit
|
461.6m
BRL
|
Operating Expenses
|
-157.5m
BRL
|
Operating Income
|
304.1m
BRL
|
Other Expenses
|
-424.1m
BRL
|
Net Income
|
-120m
BRL
|
Free Cash Flow Analysis
Kora Saude Participacoes SA
BRL | |
Free Cash Flow | BRL |
During Q2 2024, Kora Saúde saw a modest 2% revenue growth to BRL 583 million, despite terminating partnerships with several insurance operators. Adjusted EBITDA stood at BRL 117 million, a drop from BRL 130 million in Q2 2023. Oncology services experienced robust growth, contributing BRL 46 million to net revenue. The company's occupancy rate remained strong at 79%. Significant efforts were made to enhance working capital and manage debt, including issuing debentures extending to 2029 and improving payment terms. Kora is optimistic about future growth, aligning strategies with insurance operators and planning new oncology centers.
What is Earnings Call?
KRSA3 Profitability Score
Profitability Due Diligence
Kora Saude Participacoes SA's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
Kora Saude Participacoes SA's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
KRSA3 Solvency Score
Solvency Due Diligence
Kora Saude Participacoes SA's solvency score is 25/100. The higher the solvency score, the more solvent the company is.
Score
Kora Saude Participacoes SA's solvency score is 25/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
KRSA3 Price Targets Summary
Kora Saude Participacoes SA
According to Wall Street analysts, the average 1-year price target for KRSA3 is 36.9 BRL with a low forecast of 5.05 BRL and a high forecast of 126 BRL.
Dividends
Current shareholder yield for KRSA3 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Kora Saude Participaçoes SA engages in managing health care facilities. The company is headquartered in Vitoria, Espirito Santo. The company went IPO on 2021-08-13. With a presence in the management of hospital beds in five states (Espirito Santo, Mato Grosso, Tocantins, Goiania and Ceara) and in the satellite cities of the Federal District, the Company also operates a park offering diagnostic and therapeutic support services, including oncology, clinical, radiology, hemodynamics and others. The firm has hospital expansion (brownfields) and hospital construction (greenfields) projects. The vast majority of professionals who provide services in the Company's hospitals are independent.
Contact
IPO
Employees
Officers
The intrinsic value of one KRSA3 stock under the Base Case scenario is 26.81 BRL.
Compared to the current market price of 6.63 BRL, Kora Saude Participacoes SA is Undervalued by 75%.